|
[PMID]: | 27468059 |
[Au] Autor: | Peters PJ; Pontones P; Hoover KW; Patel MR; Galang RR; Shields J; Blosser SJ; Spiller MW; Combs B; Switzer WM; Conrad C; Gentry J; Khudyakov Y; Waterhouse D; Owen SM; Chapman E; Roseberry JC; McCants V; Weidle PJ; Broz D; Samandari T; Mermin J; Walthall J; Brooks JT; Duwve JM; Indiana HIV Outbreak Investigation Team |
[Ad] Endereço: | From the Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta (P.J.P., K.W.H., M.R.P., R.R.G., M.W.S., W.M.S., Y.K., S.M.O., V.M., P.J.W., D.B., T.S., J.M., J.T.B.); and the Indiana State Department of |
[Ti] Título: | HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. |
[So] Source: | N Engl J Med;375(3):229-39, 2016 Jul 21. | [Is] ISSN: | 1533-4406 |
[Cp] País de publicação: | United States |
[La] Idioma: | eng |
[Ab] Resumo: | BACKGROUND: In January 2015, a total of 11 new diagnoses of human immunodeficiency virus (HIV) infection were reported in a small community in Indiana. We investigated the extent and cause of the outbreak and implemented control measures. METHODS: We identified an outbreak-related case as laboratory-confirmed HIV infection newly diagnosed after October 1, 2014, in a person who either resided in Scott County, Indiana, or was named by another case patient as a syringe-sharing or sexual partner. HIV polymerase (pol) sequences from case patients were phylogenetically analyzed, and potential risk factors associated with HIV infection were ascertained. RESULTS: From November 18, 2014, to November 1, 2015, HIV infection was diagnosed in 181 case patients. Most of these patients (87.8%) reported having injected the extended-release formulation of the prescription opioid oxymorphone, and 92.3% were coinfected with hepatitis C virus. Among 159 case patients who had an HIV type 1 pol gene sequence, 157 (98.7%) had sequences that were highly related, as determined by phylogenetic analyses. Contact tracing investigations led to the identification of 536 persons who were named as contacts of case patients; 468 of these contacts (87.3%) were located, assessed for risk, tested for HIV, and, if infected, linked to care. The number of times a contact was named as a syringe-sharing partner by a case patient was significantly associated with the risk of HIV infection (adjusted risk ratio for each time named, 1.9; P<0.001). In response to this outbreak, a public health emergency was declared on March 26, 2015, and a syringe-service program in Indiana was established for the first time. CONCLUSIONS: Injection-drug use of extended-release oxymorphone within a network of persons who inject drugs in Indiana led to the introduction and rapid transmission of HIV. (Funded by the state government of Indiana and others.). |
[Mh] Termos MeSH primário: |
Surtos de Doenças Infecções por HIV/epidemiologia HIV-1/genética Oximorfona/administração & dosagem Abuso de Substâncias por Via Intravenosa/complicações
|
[Mh] Termos MeSH secundário: |
Adolescente Adulto Coinfecção Busca de Comunicante Infecções por HIV/transmissão Hepatite C/epidemiologia Seres Humanos Indiana/epidemiologia Masculino Meia-Idade Uso Comum de Agulhas e Seringas/efeitos adversos Filogenia Apoio Social Adulto Jovem
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S. |
[Nm] Nome de substância:
| 9VXA968E0C (Oxymorphone) |
[Em] Mês de entrada: | 1608 |
[Cu] Atualização por classe: | 160729 |
[Lr] Data última revisão:
| 160729 |
[Sb] Subgrupo de revista: | AIM; IM |
[Da] Data de entrada para processamento: | 160729 |
[St] Status: | MEDLINE |
[do] DOI: | 10.1056/NEJMoa1515195 |
|
|
|